Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis

BACKGROUND: Unresectable hepatocellular carcinoma (HCC) has a poor prognosis. According to the HCC management guidelines in China, the standard treatment of Barcelona Clinic Liver Cancer (BCLC) stage B or C HCC with portal vein tumour thrombosis (PVTT) is chemoembolization. However, some patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shiguang, Yu, Wenchang, Zhang, Kongzhi, Liu, Weifu, Wang, Xiaolong, Chen, Chuanben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106995/
https://www.ncbi.nlm.nih.gov/pubmed/35582475
http://dx.doi.org/10.1093/gastro/goac016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106995/
https://www.ncbi.nlm.nih.gov/pubmed/35582475
http://dx.doi.org/10.1093/gastro/goac016

Ejemplares similares